期刊文献+

脓毒症患者CD14^+CD16^+单核细胞的作用探讨 被引量:3

Study of CD14+CD16+ monocyte in patients with sepsis
下载PDF
导出
摘要 目的观察脓毒症患者外周血单核细胞CD14^+CD16-、CD14^+CD16+、CD14-CD16^+三个亚群表达HLA-DR、CD14、CD16的异同,并分析CD14^+CD16^+单核细胞的特点。方法选取67例脓毒症患者为脓毒症组和15例健康志愿者作为对照组,脓毒症组根据疾病严重程度分为脓毒症(15例)、重症脓毒症(41例)和脓毒性休克组(11例),收集临床资料,计算APACHEII评分,流式细胞仪检测单核细胞各亚群CD14、CD16、HLA—DR的表达。结果脓毒症患者CD14^+CD16^+单核细胞数目较正常对照组显著升高(P〈0.01);脓毒症患者单核细胞HLA—DR、CD14平均荧光强度均较健康对照组明显降低,并随着脓毒症患者病情由轻到重而逐渐下降;各组中CD14^+CD16^+单核细胞相对高表达HLA—DR、CD14;单核细胞HLA—DR表达与临床指标间存在较好的相关关系。结论①脓毒症患者单核细胞HLA—DR表达显著降低;@CD14^+CD16^+单核细胞在脓毒症发病的免疫机制中可能起到重要作用。 Objective To observe the expression of HLA-DR, CD14 and CD16 for the different subgroup of monocyte, and analyze the feather of CD14^+CD16^+ monocyte. Methods Sixty-seven cases admitted to Emergency ICU and Surgery ICU of the hospital between March and August, 2009 were divided into sepsis group (n=15), severe sepsis group (n=41), and septic shock group (n=11), versus the control group of healthy people (n=15). The frequencies of CD14, CD16 and HLA-DR of monocyte were detected by flow cytometric analysis. Simultaneously, clinical data were collected and to calculate APACHE II scores. Results A significant increase in the number of CD14^+CD16^+ monocyte of sepsis patients were observed compared with the control group; MFI of HLA-DR, CD14 were significantly lower of sepsis group than the control group, and MFI reflected lower with Exacerbations. HLA-DR and CD14 were highly expressed in CD14^+CD16^+ monocyte. HLA-DR expression of monocyte is mutually related with the clinical indicators. Conclusion ① HLA-DR Expression of monocyte in sepsis patients reflects significantly lower;② CD14^+CD16^+ monocyte might play a key role in the Immune pathogenesis of sepsis.
出处 《中国急救复苏与灾害医学杂志》 2013年第8期717-720,共4页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 CD14^+CD16^+ 单核细胞 脓毒症 感染 人白细胞抗原DR 白细胞分化抗原14 CD14^+CD16^+ monocyte Sepsis Infection Human leukocyte antigen DR CD14
  • 相关文献

参考文献28

  • 1李萌芳,洪广亮,梁欢,卢中秋,邱俏檬,吴斌.血必净注射液对脓毒症患者细胞免疫的影响[J].中国急救复苏与灾害医学杂志,2010(9):832-834. 被引量:6
  • 2胡森,盛志勇.多器官功能障碍综合征研究和治疗的进展与展望[J].感染.炎症.修复,2003,4(2):116-121. 被引量:1
  • 3Heine GH, Ulrich C, Seibert E,et al. CD14(++)CD16+ monocytes but nottotal monocyte numbers predict cardiovascular events in dialysis patients.Kidney Int, 2008,73(5): 622-629. 被引量:1
  • 4Buechler C.Ritter M.Orso E.et al. Regulation of scavenger receptor CD163expression in human monocytes and macrophages by pro- andantiinflammatory stimnli/J Leukoc Biol, 2000, 67(1): 97-103. 被引量:1
  • 5Skrzeczynska-Moncznik J.Bzowska M, Loseke S, et al/Peripheral bloodCD14high CD16+ monocytes are main producers of IL-10/Scand JImmunol.2008.67(2): 152-159. 被引量:1
  • 6Moniuszko M.Bodzenta-Lukaszyk A, Kowal K.et al/Enhanced frequenciesof CD14++CD16 + , but not CD14 + CD16' peripheral blood monocytes insevere asthmatic patients/Clin Immunol, 2009,130(3): 338-346. 被引量:1
  • 7Ziegler-Heitbrock HW, Fingerle G, Strobel M, et al. The novel subset ofCD14*/CD16* blood monocytes exhibits features of tissue macrophages/EurJ Immunol’ 1993, 23(9): 2053-2058. 被引量:1
  • 8Frankenberger M, Stemsdorf T, Pechumer H, et al. Differential cytokineexpression in human blood monocyte subpopulations: a polymerase chainreaction analysis /Blood, 1996, 87(1): 373-377. 被引量:1
  • 9Nockher WA, Bergmann L, Scherberich JE. Increased soluble CD14 serumlevels and altered CD14 expression of peripheral blood monocytes inHIV-infected patients/Clin Exp Immunol, 1994, 98(3): 369-374. 被引量:1
  • 10Nockher WA, Scherberich JE. Expanded CD14 + CD16 + monocytesubpopulation in patients with acute and chronic infections undergoinghemodialysis.Infect Immun, 1998, 66(6): 2782-2790. 被引量:1

二级参考文献64

  • 1董月青,姚咏明.脓毒症中细胞免疫紊乱的机制[J].中国危重病急救医学,2004,16(10):636-638. 被引量:50
  • 2马涛,尤胜义.淋巴细胞凋亡、免疫抑制和脓毒症[J].国外医学(外科学分册),2005,32(1):35-38. 被引量:26
  • 3王胜军,许化溪,杨胜利.CD4^+CD25^+调节性T细胞[J].细胞生物学杂志,2005,27(1):61-65. 被引量:20
  • 4Baron RM,Baron MJ,Perrella MA.Pathobiology of sepsis:are we still asking the same questions? Am J Respir Cell Mol Biol,2006,34(2):129-134. 被引量:1
  • 5Bone RC.Towards all epidemiology and nature history of SIRS.JAMA,1992,268(24):3452-3455. 被引量:1
  • 6Dellinger RP,Carlet JM,Masur H.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.Crit Care Med,2004,32(3):858-873. 被引量:1
  • 7Cavaillon JM,Adib-Conquy M,Cloez-Tayarani I,et al.Immunodepressjon in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon:a review.J Endotoxin Res,2001,7(2):85-93. 被引量:1
  • 8Wahl SM,Wen J,Moutsopoulos N.TGF-beta:a mobile purveyor of immune privilege.Immunol Rev,2006,213 213-227. 被引量:1
  • 9Omer FM,de Souza JB,Riley EM.Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections.J Immunol,2003,171(10):5430-5436. 被引量:1
  • 10Kumar A,Kumar A,Paladugu B.Transforming'growth faetor-betal blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha,interleukin-l beta,and human septic shock serum.Crit Care Med,2007,35(2):358-364. 被引量:1

共引文献119

同被引文献45

  • 1De Blasi RA. Severe sepsis and septic shock [J]. N Engl J Med, 2013, 369 ( 21 ) : 2062-2063. DOI: 10. 1056/ NEJMra1208623. 被引量:1
  • 2Zhou J, Qian C, Zhao M, et al. Epidemiology and outcome of severe sepsis and septic shock in intensive care units in China's Mainland [J]. PLoS One, 2014, 9 (9): el07181. 1301: 10. 1371/journal. pone. 0107181. eCollection 2014. 被引量:1
  • 3Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family [ J]. Nat Rev Immunol, 2010, 10 (2): 103-110. DOI: 10. 1038/nri2692. 被引量:1
  • 4Rostan O, Arshad MI, Piquet-Pellorce C, et al. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases [J]. Infect Immun, 2015, 83 (5): 1738-1748. DOI: 10. 1128/1AI. 02908-14. 被引量:1
  • 5Palmer G, Lipsky BP, Smithgall MD, et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 [J]. Cytokine, 2008, 42 (3): 358-364. DOI: 10. 1016/j. cyto. 2008. 03. 008. 被引量:1
  • 6Alves-Filho JC, Sonego F, Souto FO, et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection [J]. Nat Med, 2010, 16 (6): 708-712. DOI: 10. 1038/nm. 2156. 被引量:1
  • 7T. Roger, T. Calandra. Interleukin-33 safeguards neutrophils in sepsis [J]. Nat Med, 2010, 16 (6): 638-639. DOI: 10. 1038/nm0610-638. 被引量:1
  • 8Fan D, Ding N, Yang T, et al. Single nueleotide polymorphisms of the interleukin-33 ( IL-33 ) gene are assoeiated with ankylosing spondylitis in Chinese individuals : a ease-control pilot study [ J ]. Seand J Rheumatol, 2014, 43 (5) : 374-379. DOI: 10. 3109/ 03009742. 2014. 882408. 被引量:1
  • 9Tu X, Nie S, Liao Y, et al. The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Hart population [J]. Am J Hum Genet, 2013, 93 (4): 652-660. DOI: 10. 1016/j. ajhg. 2013. 08. 009. 被引量:1
  • 10Gudbjartsson DF, Bjomsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma andmyocardial infarction [ J]. Nat Genet, 2009, 41 (3) : 342-347. DOI: 10. 1038/ng. 323. 被引量:1

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部